Table 2 Treatment
| n | % | |
|---|---|---|
| Surgery N = 42 | ||
| Hysterectomy and bilateral salpingo-oophorectomy | 42 | 100% |
| Lymphadenectomy | ||
| Pelvic | 15 | 35.7% |
| Pelvic and paraaortic | 17 | 40.5% |
| None | 10 | 23.8% |
| Adjuvant chomotherapy N = 42 | ||
| Carboplatin/paclitaxel | 7 | 16.7% |
| None | 35 | 83.3% |
| Adjuvant radiotherapy N = 42 | ||
| Intravaginal HDR brachytherapy alone | 5 | 11.9% |
| Intravaginal HDR brachytherapy and external beam radiotherapy | 37 | 88.1% |